Wedbush Reiterates an 'Outperform' on Medivation (MDVN); Raising PT on Early Approval
Tweet Send to a Friend
Wedbush reiterates an 'Outperform' on Medivation (NASDAQ: MDVN) price target of $118.00 (from $100.00).
Analyst, David M. Nierengarten, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, David M. Nierengarten, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
